BioSante

Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
Bradenton Herald, FL
Sat, 02/11/12 - 12:54 pm
BioSante
BioSante: LibiGel Lives On, FDA Word On Bio-T-Gel May Come At Any Time
Seeking Alpha
Fri, 02/10/12 - 10:50 am
LibiGel
FDA
BioSante
Bio-T-Gel
female sexual dysfunction
Teva Pharmaceuticals
hypogonadism
3 Biotech Companies Down But Not Out
Seeking Alpha
Wed, 02/8/12 - 09:34 am
Arena
Vivus
Orexigen
Biocryst
BioSante
6 Drug Stocks Unworthy of Biotech Bull Market
TheStreet.com
Tue, 02/7/12 - 10:49 am
Cytori
Regeneron
Human Genome Sciences
Galena Biopharma
BioSante
EntreMed
What's Going on With These Biotech Stocks?
Motley Fool
Sat, 02/4/12 - 03:26 pm
Cell Therapeutics
BioSante
Teva Pharmaceuticals
Aduro BioTech
Ariad Pharmaceuticals
Merck
2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
Seeking Alpha
Tue, 01/31/12 - 02:44 pm
Abbott Laboratories
Apricus Biosciences
Warner Chilcott
BioSante
The Best Biotech Stocks Of 2012
Seeking Alpha
Mon, 01/23/12 - 02:19 pm
Advanced Cell Technologies
Aeterna Zentaris
Antares
BioSante
Geron
Hikma
Keryx
Pfizer
Sanofi
Teva Pharmaceuticals
Transcept
Yakult Honsha
Watson Pharmaceuticals
3 Biotechs Hopefully To Get Rich Or Die Trying
Seeking Alpha
Wed, 01/4/12 - 09:28 am
Advanced Cell Technologies
Aeterna Zentaris
BioSante
Dendreon
Keryx
[video]4 Biotechs Dominating the Week
Motley Fool
Mon, 12/19/11 - 04:06 pm
YM BioSciences
BioSante
Pharmasset
Alexa
3 Biotechs That Were Crushed This Week And Why
Seeking Alpha
Sat, 12/17/11 - 11:36 am
Antares
BioSante
Inhibitex
BioSante’s Female Desire Drug Fails to Boost Libido in Late-Stage Studies
Bloomberg
Wed, 12/14/11 - 06:41 pm
BioSante
female sexual dysfunction
LibiGel
December Catalysts for Drug and Biotech Stocks
Minyanville
Sat, 12/3/11 - 11:11 am
Pfizer
Aveo Pharmaceutical
Affymax
Amgen
Antares Pharma
Celgene
ONYX Pharmaceuticals
Seattle Genetics
Micromet
YM BioSciences
Regeneron
BioSante
[video] The Next Big Thing In Biotech: Biosante
TheStreet.com
Fri, 12/2/11 - 11:19 am
BioSante
female sexual dysfunction
LibiGel
Every Biotech Is for Sale
Motley Fool
Wed, 11/30/11 - 10:45 am
ONYX Pharmaceuticals
Achillion
BioSante
Indenix
Inhibitex
GSK
Bristol-Myers Squibb
Amarin
Exelixis
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Keeping An Eye On Both BioSante And Antares Pharma
Seeking Alpha
Wed, 11/16/11 - 05:24 pm
BioSante
Antares
LibiGel
November Catalysts for Biotech and Drug Stocks
Minyanville
Mon, 10/31/11 - 11:34 am
FDA
Regeneron
Vertex
Pharmasset
pSivida
Alimera
Salix
Teva Pharmaceuticals
BioSante
Transcept
BioSante Pharmaceuticals Closes $48.0 Million Public Offering of Common Stock
Benzinga
Sat, 10/29/11 - 02:42 pm
BioSante
1 Biotech To Buy And 6 FDA Decision-Pending Biotechs To Avoid
Seeking Alpha
Fri, 10/28/11 - 11:07 am
Celgene
Pacira
Incyte
BioSante
Regeneron
Transcept
Antares
7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Bristol-Myers Squibb
Dapagliflozin
BioSante
Bio-T-Gel
Regeneron
Eylea
Transcept
Intermezzo
Incyte
ruxolitinib
Antares
Anturol

Pages